July 27, 2017
Shionogi Inc. is recalling more than 6300 bottles of mefenamic acid capsules (NDC 66993-070-30) because, during stability testing, the drug failed to meet dissolution specifications, according to the July 26, 2017, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects 30-count bottles from 2 lots: 5H66200103G (Exp. June 2018) and 7H66200103G (Exp. December 2019). Bottles from the lots were distributed nationwide.
Statin use tied to lower risk of inflammatory bowel disease
Anti-Inflammatory Med Recalled
Shionogi initiated the voluntary recall May 24, 2017. The FDA categorized it Class III July 14, 2017, suggesting use of the capsules is not likely to cause adverse health effects.
Available with a prescription, mefenamic acid is a nonsteroidal anti-inflammatory drug used for the short-term treatment of pain.